Gallicchio V S, Shedlofsky S I, Swim A T, Robinson J M, Hulette B C, Messino M J, Doukas M A
Department of Medicine, University of Kentucky, Lexington 40536-0084.
J Biol Response Mod. 1989 Aug;8(4):422-39.
Interleukin-1 (IL-1), a cytokine, primarily produced by monocytes, is the molecule involved in mediating many of the body's responses associated with infection and inflammation. More recently, IL-1 has been shown to sustain elevated levels of circulating granulocytes, stimulate the production of granulocyte-macrophage colony stimulating factors (CSFs) in vitro, increase plasma levels of CSF, and act synergistically with CSFs to increase the number of granulocyte-macrophage progenitors (colony-forming units) (CFU-GM) in vitro. The purpose of this study was to investigate the effect of murine IL-1 on steady-state hematopoiesis in vivo. C3H/HeJ or its normal littermate C3H/HeN male mice were administered either murine recombinant IL-1 at 45, 50, 200, 225, or 900 units (0.0125-0.25 micrograms)/animal, or 200 units (0.05 micrograms) of semipurified IL-1 derived from P388D1 cell culture supernatants. Because one of the responses to IL-1 is increased prostaglandin (PG) production and with the known activity of PGs on hematopoiesis, additional studies incorporated the cyclooxygenase inhibitor indomethacin (IM) (10 mg/kg body weight). In order to study the effect of IL-1 in vivo on pluripotential progenitors (CFU-S), IL-1 was compared with recombinant murine GM-CSF (50, 200, and 900 units; 0.0125, 0.05, and 0.25 micrograms). Control groups consisted of animals receiving either lipopolysaccharide (0.5 mg/kg body weight) or phosphate-buffered saline where appropriate. After 24 h, animals were sacrificed, and their peripheral blood indices and stem cell content of both bone marrow and spleen were evaluated for various committed hematopoietic progenitors: CFU-GM, CFU-Meg, CFU-E, BFU-E, and CFU-DG. Circulating neutrophils were increased following IL-1; however, this increase was reduced following IM. IL-1 marrow-derived CFU-GM, CFU-E, BFU-E, and CFU-Meg were below controls. In contrast, splenic CFU-GM and CFU-Meg were significantly elevated with increasing IL-1 concentrations. Erythroid progenitors were increased following low IL-1 concentrations and reduced in animals receiving IM, thus indicating a role for prostaglandins in the mechanism of IL-1 for influencing hematopoiesis. CFU-DG were increased, however, only when animals were pretreated with IL-1 and their cells implanted into normal hosts, not when normal cells were implanted into animals pretreated with IL-1, indicating a potential target cell effect rather than an indirect, factor-related response.(ABSTRACT TRUNCATED AT 400 WORDS)
白细胞介素 -1(IL-1)是一种主要由单核细胞产生的细胞因子,是介导身体许多与感染和炎症相关反应的分子。最近研究表明,IL-1能使循环粒细胞水平持续升高,在体外刺激粒细胞 - 巨噬细胞集落刺激因子(CSF)的产生,提高血浆中CSF水平,并与CSF协同作用增加体外粒细胞 - 巨噬细胞祖细胞(集落形成单位)(CFU - GM)的数量。本研究旨在探讨小鼠IL-1对体内稳态造血的影响。给C3H/HeJ或其正常同窝仔C3H/HeN雄性小鼠分别注射45、50、200、225或900单位(0.0125 - 0.25微克)/只的小鼠重组IL-1,或200单位(0.05微克)源自P388D1细胞培养上清液的半纯化IL-1。由于对IL-1的一种反应是前列腺素(PG)产生增加,且已知PG对造血有作用,所以额外的研究加入了环氧化酶抑制剂吲哚美辛(IM)(10毫克/千克体重)。为了研究IL-1在体内对多能祖细胞(CFU - S)的影响,将IL-1与重组小鼠GM - CSF(50、200和900单位;0.0125、0.05和0.25微克)进行比较。对照组由在适当情况下接受脂多糖(0.5毫克/千克体重)或磷酸盐缓冲盐水的动物组成。24小时后,处死动物,评估其外周血指标以及骨髓和脾脏的干细胞含量,以检测各种定向造血祖细胞:CFU - GM、CFU - Meg、CFU - E、BFU - E和CFU - DG。IL-1注射后循环中性粒细胞增加;然而,IM处理后这种增加减少。IL-1处理后骨髓来源的CFU - GM、CFU - E、BFU - E和CFU - Meg低于对照组。相反,随着IL-1浓度增加,脾脏CFU - GM和CFU - Meg显著升高。低浓度IL-1处理后红系祖细胞增加,而接受IM的动物中红系祖细胞减少,这表明前列腺素在IL-1影响造血的机制中起作用。然而CFU - DG仅在动物用IL-1预处理后其细胞植入正常宿主时增加,而正常细胞植入用IL-1预处理的动物时不增加,这表明是潜在的靶细胞效应而非间接的因子相关反应。(摘要截短至400字)